Cargando…
CoolClot, a novel hemostatic agent for controlling life-threatening arterial bleeding
BACKGROUND: Uncontrolled bleeding is the first leading cause of preventable death in the battlefield and the 2nd cause of mortality in civil accidents. Incompressible hemorrhage control is among the interventions that drastically increase the survival rate in wound individuals. We have previously sh...
Autores principales: | Mortazavi, SMJ, Tavasoli, A, Atefi, M, Tanide, N, Radpey, N, Roshan-shomal, P, Moradi, H, Taeb, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Second Affiliated Hospital of Zhejiang University School of Medicine
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4129838/ https://www.ncbi.nlm.nih.gov/pubmed/25215105 http://dx.doi.org/10.5847/wjem.j.issn.1920-8642.2013.02.007 |
Ejemplares similares
-
Clot Waveform Analysis for Hemostatic Abnormalities
por: Wada, Hideo, et al.
Publicado: (2023) -
Does short-term exposure to elevated levels of natural gamma radiation in Ramsar cause oxidative stress?
por: Mortazavi, SMJ, et al.
Publicado: (2014) -
Effectiveness of hemostatic agents in thyroid surgery for the prevention of postoperative bleeding
por: Scaroni, Martino, et al.
Publicado: (2020) -
Topical hemostatic agents in the management of upper gastrointestinal bleeding: a meta-analysis
por: Alali, Ali A., et al.
Publicado: (2023) -
Superhydrophobic hemostatic nanofiber composites for fast clotting and minimal adhesion
por: Li, Zhe, et al.
Publicado: (2019)